Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Digipath Inc (OP: DIGP )

0.0104 UNCHANGED
Last Price Updated: 3:59 PM EDT, Aug 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0104
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0104
Today's Range 0.0104 - 0.0104
52wk Range 0.0060 - 0.0700
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hypha Labs' Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily Press
Via ACCESSWIRE
CORRECTION: Hypha Laboratories Retains Integrity Media for Investor Relations and Corporate Communications
Via ACCESSWIRE

Performance

YTD
-73.33%
-73.33%
1 Month
N/A
N/A
3 Month
-46.11%
-46.11%
6 Month
-51.63%
-51.63%
1 Year
-20.61%
-20.61%

More News

Read More
CORRECTION: Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence (A.I.) Driven In-Home Mycelium Production
Via ACCESSWIRE
Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence (A.I.) Driven In-Home Mycelium Production
Via ACCESSWIRE
Hypha Laboratories Retains Integrity Media for Investor Relations and Corporate Communications
Via ACCESSWIRE
Hypha Labs Announces New Patent Filing
Via ACCESSWIRE
Hypha Labs Names Craig Ellins Chief Science Officer
Via ACCESSWIRE
Digipath Announces Results for the Fiscal Year 2021
Via NewMediaWire
Topics Cannabis
Exposures COVID-19 Cannabis
Digipath Enters Psilocybin Industry and Changes Name
Via ACCESSWIRE
Hypha Labs, Inc. to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Via ACCESSWIRE
Digipath Announces Record Earnings of $292,533 for Recent Quarter Ended June 30
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Digipath, Inc. Signs Agreement to Sell the Assets of Its Lab Subsidiary
Via NewMediaWire
Digipath, Inc. Announces Revenue Increase of Almost 18% for the Fourth Quarter of Fiscal Year 2022
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Digipath Validates and Receives Approval to Use Free DNA Removal to Test for Aspergillus
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Digipath To Test Redwood Cultivation Products, Including Mike Tyson's Ear Shaped Cannabis Gummies
Via Benzinga
Digipath to Provide Product Testing for Redwood Cultivation Products, Including Mike Tyson's New Ear Shaped Gummies, 'Mike Bites'
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Digipath Teams Up With CASPR Technologies To Determine Efficacy For New Anti-Microbial Product For Cannabis Industry
Via Benzinga
Digipath Enters into Validation Agreement with CASPR Technologies to Determine Efficacy for New Anti-Microbial Product for the Cannabis Industry
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Digipath Reports Substantial Sequential Growth In Gross Profit & Revenue In Q1
Via Benzinga
Digipath Announces Financial Results for Q1, 2022
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Digipath Obtains Coveted Compliance Testing License for California Laboratory
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Digipath Takes Over Management & Signs Letter of Intent to Acquire Majority Control of Steep Hill's Licensed Northern California Lab from Evio Labs
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Digipath, Inc. to Present at the Emerging Growth Conference on Wednesday, December 8th at 12n EST/ 9:00 am PST
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Digipath Announces Results for Third Fiscal Quarter 2021
Via NewMediaWire
Topics Cannabis Regulatory Compliance
Exposures COVID-19 Cannabis Legal
Cannabis Movers & Shakers: Nevada CCB, Digipath, Agricor And Botanacor Laboratories, Curaleaf, Hervé, HERBL
Via Benzinga
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.